SCHEMBL18924133

SCHEMBL18924133

Cc1ccc2oc3c(CCc4c5nc6ccc(C)cc6oc-5c(C)c(=O)c4C)c(=O)c(C)c(-c4c5oc6cc(OCc7ccccc7)ccc6nc-5c(-c5c6oc7ccc(OCc8ccccc8)cc7nc-6c(C)c(C)c5=O)c(C)c4=O)c-3nc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 9/20 0.37
ACHE P22303 3/20 0.36
MAOA P21397 4/20 0.35
NPC1 O15118 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA3 P07451 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA7 P43166 1/20 0.34
MTNR1A P48039 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
PKM P14618 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CASP3 P42574 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18924099 0.81 MAOB (0.50) MAOBACHEMAOANPC1MEN1
SCHEMBL18924102 0.81 MAOB (0.53) MAOBACHEMAOANPC1MEN1
SCHEMBL18924108 0.70 MAOB (0.47) MAOBACHEMAOANPC1MEN1
SCHEMBL18924109 0.70 MAOB (0.49) MAOBACHEMAOANPC1MEN1
SCHEMBL18924100 0.69 MAOB (0.52) MAOBACHEMAOANPC1MEN1
SCHEMBL18924103 0.69 PKM (0.51) MAOBACHEMAOANPC1MEN1
SCHEMBL16069568 0.69 KDM4E (0.47) NPC1MEN1KMT2APKMRAB9A
SCHEMBL16069633 0.69 NPC1 (0.46) NPC1MEN1KMT2AL3MBTL1CASP3
SCHEMBL16069583 0.69 CYP1A2 (0.53) MEN1KMT2ACA12CA1CA4
SCHEMBL16069653 0.67 CA12 (0.49) MAOBMAOACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670170-B2 Resorufin derivatives for treatment of oxidative stress disorders BIOELECTRON TECHNOLOGY CORPORATION (US) 2017-06-06 US disclosed